Asef Activators
Asef activators constitute a category of chemicals designed to modulate the activity of Asef, a guanine nucleotide exchange factor (GEF) known to promote the exchange of GDP for GTP on small GTPases, particularly of the Rho family such as Rac1. The activation of Asef is of great interest in the field of cell biology research, as Asef plays a pivotal role in actin cytoskeleton dynamics and thus regulates cell adhesion, migration, and morphology. The activators of Asef may operate through direct interaction with the protein, targeting domains that are critical for its GEF activity or its autoinhibitory state. By binding to Asef, these activators could relieve autoinhibition, thereby exposing the nucleotide exchange site and facilitating the GDP-GTP exchange on the target GTPase. This would lead to the activation of the GTPase and subsequent downstream signaling events that govern cytoskeletal reorganization and cellular processes.
Indirect activators, conversely, could enhance Asef activity by upregulating its expression, by affecting the post-translational modifications that control its function or by influencing other upstream signaling pathways that result in the activation of Asef. For instance, phosphorylation by specific kinases might increase Asef activity, and indirect activators could stimulate these kinases or inhibit phosphatases that otherwise deactivate Asef.In research, Asef activators are used to dissect the cellular and molecular mechanisms underlying the regulation of the actin cytoskeleton and related cellular behaviors. By employing these activators, scientists can investigate the specific effects of Asef activation on cell morphology, cell motility, and the dynamics of cell junctions. Moreover, understanding how Asef is regulated through these activators can reveal new insights into the complex network of intracellular signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC). PKC can phosphorylate and activate PAK1, which is a known upstream activator of Rac1. Rac1 can then activate Asef. Therefore, PMA indirectly enhances Asef activity through the PKC/PAK1/Rac1 pathway. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing the levels of cAMP. Elevated cAMP levels activate PKA, which can activate Rac1. Rac1 then activates Asef. Therefore, Forskolin indirectly enhances Asef activity through the adenylate cyclase/cAMP/PKA/Rac1 pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. Inhibition of PI3K leads to decreased Akt activity, which reduces the inhibition of Rac1. Rac1 then activates Asef. Therefore, LY294002 indirectly enhances Asef activity through the PI3K/Akt/Rac1 pathway. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts the microtubule network. Disruption of the microtubule network leads to activation of RhoA. RhoA activation leads to decreased Rac1 inhibition, which then activates Asef. Therefore, Nocodazole indirectly enhances Asef activity through the microtubule network/RhoA/Rac1 pathway. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide induces DNA damage and activates the DNA damage response pathway. Activation of this pathway leads to increased activity of Rac1, which then activates Asef. Therefore, Etoposide indirectly enhances Asef activity through the DNA damage response/Rac1 pathway. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A. Inhibition of these phosphatases leads to increased Rac1 activity, which then activates Asef. Therefore, Okadaic acid indirectly enhances Asef activity through the PP1/PP2A/Rac1 pathway. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin B binds to actin and disrupts the actin cytoskeleton. Disruption of actin leads to increased Rac1 activity, which then activates Asef. Therefore, Latrunculin B indirectly enhances Asef activity through the actin/Rac1 pathway. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes the actin filaments and leads to activation of Rac1. Rac1 then activates Asef. Therefore, Jasplakinolide indirectly enhances Asef activity through the actin/Rac1 pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a Rho-associated protein kinase (ROCK) inhibitor. Inhibition of ROCK leads to decreased RhoA activity, which reduces the inhibition of Rac1. Rac1 then activates Asef. Therefore, Y-27632 indirectly enhances Asef activity through the ROCK/RhoA/Rac1 pathway. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a specific inhibitor of Cdc42, a known regulator of Rac1. Inhibition of Cdc42 leads to increased Rac1 activity, which then activates Asef. Therefore, ML141 indirectly enhances Asef activity through the Cdc42/Rac1 pathway. | ||||||